TY - JOUR AU - Escudier, B; Lassau, N; Angevin, E TI - Phase I trial of sorafenib in combination with IFN alpha-2a in patients with unresectable and/or metastatic renal cell carcinoma or malignant melanoma JO - Clin Cancer Res VL - 13 PY - 2007 DO - 10.1158/1078-0432.CCR-06-1432 L3 - PubMed-ID: 17363536 SP - 1801 EP - 1809 N1 - et al. ER -